MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
112.79
-2.13
-1.85%
After Hours: 113.24 +0.45 +0.40% 19:59 09/11 EDT
OPEN
115.22
PREV CLOSE
114.92
HIGH
117.84
LOW
109.30
VOLUME
1.28M
TURNOVER
--
52 WEEK HIGH
126.38
52 WEEK LOW
28.66
MARKET CAP
12.19B
P/E (TTM)
264.70
1D
5D
1M
3M
1Y
5Y
1D
Corcept: Not Cheap, But Backed By Real Structural Growth
Seeking Alpha · 4d ago
Weekly Report: what happened at CORT last week (0831-0904)?
Weekly Report · 5d ago
The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index
Seeking Alpha · 6d ago
Bloom Energy Stock (BE) Is Rising 6% in Friday’s After-Hours Trading – Here’s Why
TipRanks · 09/04 23:17
Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added
Seeking Alpha · 09/04 22:20
S&P 600 adding ten companies at open on 9/21
TipRanks · 09/04 21:50
HubSpot, AGNC, Corcept, Brinker to be added to S&P 400 at open on 9/21
TipRanks · 09/04 21:45
Noteworthy ETF Outflows: SPSM, CORT, GKOS, PAYC
NASDAQ · 09/04 14:51
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. It is also conducting advanced clinical trials in patients with solid tumors, Amyotrophic Lateral Sclerosis (ALS) and liver disease. It operates through the discovery, development and commercialization of the pharmaceutical products segment. It sells Korlym and a generic version of Korlym in the United States using sales representatives to call on physicians caring for patients with hypercortisolism (Cushing’s syndrome). The Company's portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. It sells and distributes Lifyorli in the United States. It is developing its proprietary, selective cortisol modulator, relacorilant, as a treatment for patients with hypercortisolism.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.